chr2-178618216-T-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP2BP4_Moderate
The NM_001267550.2(TTN):āc.47242A>Cā(p.Asn15748His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,612,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.47242A>C | p.Asn15748His | missense_variant | 252/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.47242A>C | p.Asn15748His | missense_variant | 252/363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000856 AC: 13AN: 151932Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248010Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134546
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460688Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 726638
GnomAD4 genome AF: 0.0000856 AC: 13AN: 151932Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74204
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 03, 2013 | Variant classified as Uncertain Significance - Favor Benign. The Asn13180His var iant in TTN has not been reported in individuals with cardiomyopathy, but has be en identified in 3/3806 African American chromosomes by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS/). Asparagine (Asn) at position 13 180 is poorly conserved in evolution, including in mammals, suggesting that a ch ange at this position would be tolerated. Other computational analyses (biochemi cal amino acid properties, AlignGVGD, PolyPhen2, and SIFT) also suggest that thi s variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. The presence of the variant in the general pop ulation and poor evolutionary conservation suggest that the Asn13180His variant may be benign; however, additional studies are needed to fully assess its clinic al significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 15, 2021 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 12, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 07, 2022 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 12, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at